Publication | Open Access

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

Breast OncologyMedicinePharmacologyBreast CancerContinuous Versus IntermittentCancer TreatmentOncologyRadiation OncologySole Estrogen SubstudyEndocrine-related Cancer